Asymptomatic family members of PAH patients carrying a bone morphogenetic protein receptor type 2 (BMPR2) mutation showed significantly more often a hypertensive response of systolic pulmonary arterial pressure during low exercise compared to controls [23]. Here, BMPR2 is linked to pulmonary arterial hypertension.